Embed this press release by copying the code below:
NASDAQ:OBLN Long Term Investor Notice: Investigation of Potential Wrongdoing at Obalon Therapeutics Inc
NASDAQ:OBLN Long Term Investor Notice: Investigation of Potential Wrongdoing at Obalon Therapeutics Inc